Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

FMT study

ABSTRACT: Fecal microbiota transplantation in Parkinson's disease

PROVIDER: PRJEB68317 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR12541500_1.fastq.gz	Fastqsanger.gz
	ERR12541500_2.fastq.gz	Fastqsanger.gz
	ERR12541600_1.fastq.gz	Fastqsanger.gz
	ERR12541600_2.fastq.gz	Fastqsanger.gz
	ERR12541700_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 832

Similar Datasets

Impact of fecal microbiota transplantation (FMT) in 3 days-ABX-treated recipient mice using feces from 6 NSCLC patients at diagnosis.

Project description:This study aimed to analyze changes in gut microbiota composition in mice after transplantation of fecal microbiota (FMT, N = 6) from the feces of NSCLC patients by analyzing fecal content using 16S rRNA sequencing, 10 days after transplantation. Specific-pathogen-free (SPF) mice were used for each experiments (N=4) as controls.

2023-07-01 | E-MTAB-12812 | biostudies-arrayexpress

FMT calves

Project description:Effect of fecal microbiota transplantation on calf diarrhea

| PRJEB35993 | ENA

FMT in UC

Project description:Fecal microbiota transplantation for treatment of ulcerative colitis

| PRJEB47061 | ENA

KEEP-G06A prospective, open, single-center, single-arm phase II study of Sintilimab combined with Fruquintinib and Fecal Microbiota Transplantation(FMT) in the treatment of Non-MSI-H/dMMR advanced colorectal cancer

Project description:Interventions: experimental group:Sintilimab combined with Fruquintinib and Fecal Microbiota Transplantation(FMT) Primary outcome(s): ORR Study Design: Single arm

| 36777 | ecrin-mdr-crc

Pouchitis-FMT

Project description:Luminal and Mucosal Microbiota and Host Gene Expression in Chronic Pouchitis Patients after Fecal Microbiota Transplantation

| PRJEB52304 | ENA

FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage

Project description:A single-arm, phase II study was designed to evaluate the efficacy and safety of fecal microbiota transplantation plus Sintilimab and Fruquintinib as the later line treatment in colorectal patients with advanced stages.

| 2709355 | ecrin-mdr-crc

UC-FMT-study

Project description:The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis.

| PRJEB11841 | ENA

Exercise-acclimated microbiota improves skeletal muscle metabolism

Project description:Habitual exercise modulates the composition of the intestinal microbiota. We examined whether transplanting fecal microbiota from trained mice improved skeletal muscle metabolism in high-fat diet-fed mice. The recipient mice that received fecal samples from trained donor mice for 1 week showed elevated levels of metabolic signalings in skeletal muscle. Glucose tolerance was improved by fecal microbiota transplantation after 8 weeks of HFD administration. Intestinal microbiota may mediate exercise-induced metabolic improvement in mice. We performed a microarray analysis to compare the metabolic gene expression profiles in the skeletal muscle from each mouse.

2022-06-30 | GSE201202 | GEO

Effect of morphine treatment on microbiome in the context of microbial transplant.

Project description:Morphine causes microbial dysbiosis. In this study we focused on restoration of native microbiota in morphine treated mice and looked at the extent of restoration and immunological consequences of this restoration. Fecal transplant has been successfully used clinically, especially for treating C. difficile infection2528. With our expanding knowledge of the central role of microbiome in maintenance of host immune homeostasis17, fecal transplant is gaining importance as a therapy for indications resulting from microbial dysbiosis. There is a major difference between fecal transplant being used for the treatment of C. difficile infection and the conditions described in our studies. The former strategy is based on the argument that microbial dysbiosis caused by disproportionate overgrowth of a pathobiont can be out-competed by re-introducing the missing flora by way of a normal microbiome transplant. This strategy is independent of host factors and systemic effects on the microbial composition. Here, we show that microbial dysbiosis caused due to morphine can be reversed by transplantation of microbiota from the placebo-treated animals.

2016-06-01 | E-MTAB-3723 | biostudies-arrayexpress

Project description:Fecal microbiota of patients with Parkinson's disease

| PRJNA1159471 | ENA